Immunai
Immune system research and development
- B2B
- AI-native
About Immunai
Utilizing single-cell biology and AI to map and reprogram the immune system for innovative drug development and improved patient outcomes
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- New York, United States
- Founded
- 2019
- Revenue
- $21.2M – $167MTamtam estimate
- Website
- immunai.com
- linkedin.com/company/immunai
Immunai at a glance
Immunai is a B2B company in the Biotechnology Research industry, headquartered in New York, United States.
Immunai was founded in 2019.
Immunai has 51–250 employees.
Immunai's revenue is $21.2M – $167M (Tamtam estimate).
Selling to companies like Immunai?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies